Lowe Syndrome
Oncology·MeSH: Oculocerebrorenal Syndrome
Prevalence
0.5 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| piclidenoson | Can-Fite BioPharma Ltd. (CANF) |
Frequently asked questions
How many drugs are in development for Lowe Syndrome?
BioSniper tracks 1 drug in development for Lowe Syndrome across 1 company.
How many clinical trials target Lowe Syndrome?
There are 2 clinical trials targeting Lowe Syndrome tracked by BioSniper.
What is the prevalence of Lowe Syndrome?
The estimated prevalence of Lowe Syndrome is approximately 0.5 per 100,000 population.
Deep-dive into Lowe Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis